CK0803 ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	1

2. 筋萎縮性側索硬化症

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05695521 (ClinicalTrials.gov)	January 30, 2023	3/1/2023	Regulatory T Cells for Amyotrophic Lateral Sclerosis	Phase 1 Safety Run-in Study and Phase 1b Randomized, Double Blinded, Placebo Controlled Trial	Amyotrophic Lateral Sclerosis	Biological: CK0803;Other: Excipient	Cellenkos, Inc.	NULL	Not yet recruiting	18 Years	95 Years	All	66	Phase 1	United States